Citation: | CHENG Lu, LIN Yunfei, DING Li, WEN Aidong, WU Yan, ZHANG Run. Pharmacokinetics of butoconazole nitrate suppositories in human[J]. Journal of China Pharmaceutical University, 2013, 44(6): 548-552. DOI: 10.11665/j.issn.1000-5048.20130612 |
[1] |
Jacobson JB,Hajman AJ,Wiese J,et al.A new vaginal antifungal agent-butoconazole nitrate[J].Acta Obstet Gyn Scan,1985,64(3):241-244.
|
[2] |
Adamson GD, Brown D Jr, Standard JV, et al. Three-day treatment with butoconazole vaginal suppositories for vulvovaginal candidiasis[J].J Reprod Med,1986,31(2):131-132.
|
[3] |
Hajman AJ. Vulvovaginal candidosis: comparison of 3-day treatment with 2% butoconazole nitrate cream and 6-day treatment with 1% clotrimazole cream[J].J Int Med Res,1988,16(5):367-375.
|
[4] |
Brown D,Henzl MR,Kaufman RH.Butoconazole nitrate 2% for vulvovaginal candidiasis.New,single-dose vaginal cream formulation vs.seven-day treatment with miconazole nitrate.Gynazole 1 study group[J].J Reprod Med,1999,44(11):933-993.
|
[5] |
US FDA.Guidance for industry: bioanalytical method validation [EB/OL].USA,US Department of Health and Human Services,2001[2011-09-10].http: //www.fda.gov /downloads /Drugs /Guidance Compliance Regulatory Information /Guidances / UCM070107.pdf.
|
[6] |
Chu Y,Ding L,Liu HY,et al.Determination of potassium oxonate in human plasma and urine and its pharmacokinetics and accumulation evaluation in human[J].J China Pharm Univ(中国药科大学学报),2011,42(5):436-442.
|
[7] |
Droegemueller W,Adamson DG,Brown D,et al.Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis[J].Obstet Gynecol,1984,64(4):530-534.
|
[8] |
Tatum DM, Eggleston M. Butoconazole nitrate[J]. Infect Cont Hosp Ep,1988,9(3):122-124.
|
[9] |
Wang Q,Chen GS.Progress in vaginal delivery systems[J].Chin J Mod Appl Pharm(中国现代应用药学),2005,22(1):34-36.
|